Monopar Therapeutics Inc.
Records under this name other than the patents Monopar Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 9 of 9 · Back to Monopar Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,158,591 | Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines Term ended Ended no later than Apr 21, 2026 · USPTO record | Term ended | Ended no later than Apr 21, 2026 | USPTO record |
| US 11,090,290 | Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy Lapsed on the fee record Ended Aug 17, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 17, 2025 | USPTO record |
| US 7,244,829 | Compositions and processes for preparing 13-deoxy-anthracyclines Term ended Term ended Jul 29, 2025 · USPTO record | Term ended | Term ended Jul 29, 2025 | USPTO record |
| US 7,772,379 | Compositions and processes for preparing 13-deoxy-anthracyclines Term ended Term ended Dec 31, 2024 · USPTO record | Term ended | Term ended Dec 31, 2024 | USPTO record |
| US 8,097,707 | Compositions and processes for preparing 13-deoxy-anthracyclines Term ended Ended no later than Nov 8, 2024 · USPTO record | Term ended | Ended no later than Nov 8, 2024 | USPTO record |
| US 10,675,271 | Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy Lapsed on the fee record Ended Jun 9, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 9, 2024 | USPTO record |
| US 9,192,599 | Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers Lapsed on the fee record Ended Nov 24, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 24, 2023 | USPTO record |
| US 5,942,605 | 5-Imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them Term ended Term ended no later than Aug 24, 2019 · Low confidence | Term ended | Term ended no later than Aug 24, 2019 | Low confidence |
| US 5,948,896 | Processes for preparing 13-deoxy anthracycline derivatives Term ended Term ended no later than Sep 7, 2019 · Low confidence | Term ended | Term ended no later than Sep 7, 2019 | Low confidence |